-
Summary Basis of Decision for AhzantiveHealth Canada RSS – Drug Products, Drugs and Health Products
Health Canada Summary Basis of Decision 2026-02-02. Ahzantive, 2 mg/0.05 mL aflibercept, solution, Valorum Biologics LLC. Submission Control Number 292152 Read more
-
Summary Basis of Decision for ElfabrioHealth Canada RSS – Drug Products, Drugs and Health Products
Health Canada Summary Basis of Decision 2026-02-09. Elfabrio, pegunigalsidase alfa 5 mg/2.5 mL and 20 mg/10 mL, solution, Chiesi Farmaceutici S.p.A. Submission Control Number 287986 Read more
-
Summary Basis of Decision for EnzeevuHealth Canada RSS – Drug Products, Drugs and Health Products
Health Canada Summary Basis of Decision 2026-01-19. Enzeevu, aflibercept, 2 mg/0.05 mL (40 mg/mL), solution, Sandoz Canada Inc. Submission Control Number 290401 Read more
-
Summary Basis of Decision for ImaavyHealth Canada RSS – Drug Products, Drugs and Health Products
Health Canada Summary Basis of Decision 2026-01-31. Imaavy, nipocalimab 300 mg/1.62 mL (185 mg/mL) and 1,200 mg/6.5 mL (185 mg/mL), solution, Janssen Inc. Submission Control Number 293081 Read more
-
Summary Basis of Decision for NilemdoHealth Canada RSS – Drug Products, Drugs and Health Products
Health Canada Summary Basis of Decision 2026-02-02. Nilemdo, 180 mg bempedoic acid, tablet, HLS Therapeutics Inc. Submission Control Number 291745 Read more
-
Secretary-General of ASEAN delivers remarks at Dinner Reception with Japanese Partners and StakeholdersASEAN Main Portal
Secretary-General of ASEAN, Dr. Kao Kim Hourn, delivered remarks at a dinner reception held at the Imperial Hotel Tokyo, on 5 March 2026, bringing together Ambassadors of ASEAN Members in Tokyo, members of the Economic Research Institute for ASEAN and East Asia (ERIA) Parliamentary Read more